Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (591-600 of 1,011) with videos related to

Pageof 102
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 21, 2008
The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European womenA Kautzky-Willer, D Bancher-Todesca, R Weitgasser, et al.
Journal of the American College of Cardiology|December 1, 1983
Electrophysiologic actions of high plasma concentrations of propranolol in human subjectsH J Duff, D M Roden, L Brorson, et al.
Clinical Pharmacology and Therapeutics|January 21, 2011
The emerging role of electronic medical records in pharmacogenomicsR A Wilke, H Xu, J C Denny, et al.
Drug Safety|August 2, 2018
Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors"Rebecca N Jerome, Jill M Pulley, Dan M Roden, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infectionsDaniel K Benjamin, Timothy Driscoll, Nita L Seibel, et al.
Pharmacogenetics and Genomics|September 16, 2016
Genetic determinants of variability in warfarin response after the dose-titration phaseOtito F Iwuchukwu, Andrea H Ramirez, Yaping Shi, et al.
The Journal of Clinical Investigation|March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockadeK T Murray, C Reilly, R P Koshakji, et al.
Journal of Cardiovascular Electrophysiology|September 1, 1994
Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devicesD S Echt, S T Gremillion, J T Lee, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 4, 2013
Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipientsMatthew Oetjens, William S Bush, Kelly A Birdwell, et al.
JACC. Clinical Electrophysiology|January 31, 2021
Genetic Testing for Early Onset Atrial Arrhythmias Changes Clinical Management: 2 Cases of Cardiac EmerinopathyZachary T Yoneda, Katherine C Anderson, Juan Carlos Estrada, et al.
Pageof 102

Showing results (591-600 of 1,011) with videos related to

Sort By:
Pageof 102
The Journal of Clinical Endocrinology and Metabolism|February 21, 2008
The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European womenA Kautzky-Willer, D Bancher-Todesca, R Weitgasser, et al.
Journal of the American College of Cardiology|December 1, 1983
Electrophysiologic actions of high plasma concentrations of propranolol in human subjectsH J Duff, D M Roden, L Brorson, et al.
Clinical Pharmacology and Therapeutics|January 21, 2011
The emerging role of electronic medical records in pharmacogenomicsR A Wilke, H Xu, J C Denny, et al.
Drug Safety|August 2, 2018
Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors"Rebecca N Jerome, Jill M Pulley, Dan M Roden, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infectionsDaniel K Benjamin, Timothy Driscoll, Nita L Seibel, et al.
Pharmacogenetics and Genomics|September 16, 2016
Genetic determinants of variability in warfarin response after the dose-titration phaseOtito F Iwuchukwu, Andrea H Ramirez, Yaping Shi, et al.
The Journal of Clinical Investigation|March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockadeK T Murray, C Reilly, R P Koshakji, et al.
Journal of Cardiovascular Electrophysiology|September 1, 1994
Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devicesD S Echt, S T Gremillion, J T Lee, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 4, 2013
Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipientsMatthew Oetjens, William S Bush, Kelly A Birdwell, et al.
JACC. Clinical Electrophysiology|January 31, 2021
Genetic Testing for Early Onset Atrial Arrhythmias Changes Clinical Management: 2 Cases of Cardiac EmerinopathyZachary T Yoneda, Katherine C Anderson, Juan Carlos Estrada, et al.
Pageof 102